Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 332

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 332
---
 for the medical, dental, and vision plans for our executive officers. For the NEOs, we pay for and on behalf of each NEO life insurance premiums. We generally do not provide perquisites or personal benefits to our NEOs, except in limited circumstances.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth certain information regarding outstanding stock options held by the named executive officers as of December 31, 2024. 

    Name
     
    Number ofSecuritiesUnderlyingUnexercisedOptions (#)Exercisable

    Number ofSecuritiesUnderlyingUnexercisedOptions (#)Unexercisable

    OptionExercisePrice ($)

    OptionExpirationDate

    Dr. James Bianco

    178,901

    -

    $
    3.69

    7/1/2031

    President and Chief Executive Officer

    23,853

    47,707
     
    (1)
     
    $
    3.69

    4/7/2033

    191,281
     
    (3)

    $
    4.14

    2/28/2034

    1,065,990
     
    (4)

    $
    4.94

    11/12/2034

    Dan Dearborn

    33,991

    -

    $
    2.42

    1/17/2026

    Chief Financial Officer

    68,439

    -

    $
    2.42

    12/20/2026

    155,046

    77,525
     
    (2)
     
    $
    3.69

    11/15/2032

    5,248

    10,496
     
    (1)
     
    $
    3.69

    4/7/2033

    66,659
     
    (3)

    $
    4.14

    2/28/2034

    489,848
     
    (4)

    $
    4.94

    11/12/2034

    Dennis Yamashita

    196,791

    $
    4.14

    2/28/2034

    Chief Scientific Officer

    Robert Hoffman

    2